Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates

References

• LookerACBorrudLGDawson-HughesBShepherdJAWrightNCOsteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005–2008NCHS Data Brief2012931822617299
   PubMedGoogle Scholar
• Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause SocietyMenopause20101712554 quiz 55–5620061894
   PubMed Web of Science ®Google Scholar
• WattsNBBilezikianJPCamachoPMAmerican Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosisEndocr Pract201016Suppl 313721224201
   PubMedGoogle Scholar
• CosmanFde BeurSJLeBoffMSClinician’s guide to prevention and treatment of osteoporosisOsteoporos Int201425102359238125182228
   PubMed Web of Science ®Google Scholar
• SirisESModiATangJGandhiSSenSSubstantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysisCurr Med Res Opin201430112313024102262
   PubMed Web of Science ®Google Scholar
• MeadowsESMitchellBDBolgeSCJohnstonJAColNFFactors associated with treatment of women with osteoporosis or osteopenia from a national surveyBMC Womens Health201212122225919
   PubMed Web of Science ®Google Scholar
• ImazIZegarraPGonzalez-EnriquezJRubioBAlcazarRAmateJMPoor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysisOsteoporos Int201021111943195119967338
   PubMed Web of Science ®Google Scholar
• RossSSamuelsEGairyKIqbalSBadamgaravESirisEA meta-analysis of osteoporotic fracture risk with medication nonadherenceValue Health201114457158121669382
   PubMed Web of Science ®Google Scholar
• DiabDLWattsNBBisphosphonates in the treatment of osteoporosisEndocrinol Metab Clin North Am201241348750622877426
   PubMed Web of Science ®Google Scholar
• FraserLAVogtKNAdachiJDThabaneLFracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysisTher Clin Risk Manag2011715716621691586
   PubMed Web of Science ®Google Scholar
• CurtisJRWestfallAOChengHDelzellESaagKGRisk of hip fracture after bisphosphonate discontinuation: implications for a drug holidayOsteoporos Int200819111613162018483689
   PubMed Web of Science ®Google Scholar
• NeunerJMLaudPWSchapiraMMA randomized study of the effect of 5-year and lifetime hip fracture risk information on physician recommendations for management of low bone densityJ Clin Densitom200710437037517888700
   PubMed Web of Science ®Google Scholar
• SinskyCAForeman-HoffmanVCramPThe impact of expressions of treatment efficacy and out-of-pocket expenses on patient and physician interest in osteoporosis treatment: implications for pay-for-performance programsJ Gen Intern Med200823216416818163191
   PubMed Web of Science ®Google Scholar
• WeissTWSirisESBarrett-ConnorEMillerPDMcHorneyCAOsteoporosis practice patterns in 2006 among primary care physicians participating in the NORA studyOsteoporos Int200718111473148017577594
   PubMed Web of Science ®Google Scholar
• CopherRBuzinecPZarotskyVKazisLIqbalSUMacariosDPhysician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claimsCurr Med Res Opin201026477778520095797
   PubMed Web of Science ®Google Scholar
• HaYCLeeYKLimYTJangSMShinCSPhysicians’ attitudes to contemporary issues on osteoporosis management in KoreaJ Bone Metab201421214314925006571
   PubMedGoogle Scholar
• ChitreMMHayesW3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health planJ Manag Care Pharm200814328129018439050
   PubMed Web of Science ®Google Scholar
• GourlayMLCallahanLFPreisserJSSloanePDOsteoporosis preventive care in white and black women in community family medicine settingsSouth Med J2007100767768217639746
   PubMed Web of Science ®Google Scholar
• ReginsterJYRabendaVPatient preference in the management of postmenopausal osteoporosis with bisphosphonatesClin Interv Aging20061441542318046918
   PubMed Web of Science ®Google Scholar
• BonnickSLSilvermanSTannerSBPatient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronateJ Womens Health (Larchmt)200918793594319563245
   PubMed Web of Science ®Google Scholar
• BinkleyNMartensMGSilvermanSLImproved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonatesSouth Med J2009102548649219373149
   PubMed Web of Science ®Google Scholar
• DermanRKohlesJDBabbittAGastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatmentClin Interv Aging2009435736519851511
   PubMed Web of Science ®Google Scholar
• Berecki-GisolfJHockeyRDobsonAAdherence to bisphosphonate treatment by elderly womenMenopause200815598499018520695
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFJErkensJAOlsonMHeringsRMDeterminants of non-compliance with bisphosphonates in women with postmenopausal osteoporosisCurr Med Res Opin20082451337134418380910
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFJGoettschWGErkensJAHeringsRMDeterminants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosisClin Ther200628223624216678644
   PubMed Web of Science ®Google Scholar
• LoJCPressmanAROmarMAEttingerBPersistence with weekly alendronate therapy among postmenopausal womenOsteoporos Int200617692292816609824
   PubMed Web of Science ®Google Scholar
• YunHCurtisJRGuoLPatterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiariesBMC Musculoskelet Disord20141511224684864
   PubMed Web of Science ®Google Scholar
• GallagherAMRietbrockSOlsonMvan StaaTPFracture outcomes related to persistence and compliance with oral bisphosphonatesJ Bone Miner Res200823101569157518505366
   PubMed Web of Science ®Google Scholar
• KothawalaPBadamgaravERyuSMillerRMHalbertRJSystematic review and meta-analysis of real-world adherence to drug therapy for osteoporosisMayo Clin Proc200782121493150118053457
   PubMed Web of Science ®Google Scholar
• MartinKEYuJCampbellHEAbarcaJWhiteTJAnalysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause costJ Manag Care Pharm201117859660921942301
   PubMed Web of Science ®Google Scholar